Natural drug delivery systems for the treatment of neurodegenerative diseases
Molecular Biology Reports · 2025
DOI: 10.1007/s11033-025-10286-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2025. Verfasst von Greta Kaspute und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nanotechnology, State Research Institute Center for Physical Sciences and Technology (FTMC), Sauletekio Av. 3, 10257, Vilnius, Lithuani…. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Drug Delivery Systems, Biological Products. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 198 Literaturangaben. Gefördert von: Research Council of Lithuania (LMTLT).
Abstract (Originalsprache)
Today, herbal drugs are prominent in the pharmaceutical industry due to their well-known therapeutic and side effects. Plant-based compounds often face limitations such as poor solubility, low bioavailability, and instability in physiological environments, restricting their therapeutic efficacy and delivery. Nanotechnology-based solutions, including nanoparticle formulations and advanced delivery systems like liposomes and transfersomes, address these issues by enhancing solubility, stability, bioavailability, and targeted delivery, thereby optimizing the therapeutic potential of phytoactive compounds. Neuroinflammation can be a cause of neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, or amyotrophic lateral sclerosis. Consequently, there is a need for the optimal delivery of a pharmacological anti-inflammatory agents to the CNS. Thus, the non-invasive administration of a stable compound at a therapeutic concentration is needed to assure molecule crossing through the blood-brain barrier. Natural resources have more structural diversity and novelty than synthetic compounds, e.g. plant-derived drug products have higher molecular weights, incorporate more oxygen atoms, and are more complex. As a result, plant-derived products have unique features which can be used to effectively modulate neuroinflammation. Therefore, this review aims to identify herbal molecules capable of targeting neuroinflammation and present novel strategies for their efficient delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nanotechnology, State Research Institute Center for Physical Sciences and Technology (FTMC), Sauletekio Av. 3, 10257, Vilnius, Lithuania.
- Department of Nanotechnology, State Research Institute Center for Physical Sciences and Technology (FTMC), Sauletekio Av. 3, 10257, Vilnius, Lithuania. arunas.ramanavicius@chf.vu.lt.
- Department of Physical Chemistry, Faculty of Chemistry and Geosciences, Institute of Chemistry, Vilnius University, Naugarduko St. 24, 03225, Vilnius, Lithuania. arunas.ramanavicius@chf.vu.lt.
- Department of Nanotechnology, State Research Institute Center for Physical Sciences and Technology (FTMC), Sauletekio Av. 3, 10257, Vilnius, Lithuania. urte.prentice@chgf.vu.lt.
- Department of Physical Chemistry, Faculty of Chemistry and Geosciences, Institute of Chemistry, Vilnius University, Naugarduko St. 24, 03225, Vilnius, Lithuania. urte.prentice@chgf.vu.lt.
Förderung
- Research Council of Lithuania (LMTLT)
Zitieren
APA
Kaspute, G., Ramanavicius, A., & Prentice, U. (2025). Natural drug delivery systems for the treatment of neurodegenerative diseases. Molecular Biology Reports. https://doi.org/10.1007/s11033-025-10286-9
Vancouver
Kaspute G, Ramanavicius A, Prentice U. Natural drug delivery systems for the treatment of neurodegenerative diseases. Molecular Biology Reports. 2025. doi:10.1007/s11033-025-10286-9
BibTeX
@article{Kaspute2025,
author = {Kaspute, Greta and Ramanavicius, Arunas and Prentice, Urte},
title = {Natural drug delivery systems for the treatment of neurodegenerative diseases},
journal = {Molecular Biology Reports},
year = {2025},
doi = {10.1007/s11033-025-10286-9}
}
EUVIMED